EFFECTS OF OVARIAN STEROIDS ON THE INHIBITION OF ATHEROSCLEROSIS IN RELATION TO THE EFFECTS ON ENDOMETRIUM
卵巢类固醇抑制动脉粥样硬化的作用与对子宫内膜的影响
基本信息
- 批准号:09671693
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
It is known that estrogen inhibits the development of atherosclerosis through the effects on lipid metabolism and the action on the vascular function. In the present study, how the ovarian steroids, estrogen and progesterone, act on the vascular wall and endometrium. Albino rabbits, six months old, were divided into six groups ; C (Sham operation), OVX (oophorectomy), OVX+E (estradiol valerate ; 5mg/body/2weeks), OVX+E+1.0P (17 alpha-hydroxyprogesterone capronate ; 125mg/body/2weeks), OVX+E+0.3P, Ovx+E+0.1P. These rabbits were provided the commercial fodder containing 0.5% cholesterol and given those steroids every two weeks. They were terminated after six months and the specimen were made for microscope and tension recording. The thickness of media of thoracic aorta was 844±78μm in OVX ; 2.5 fold thicker than that in non-cholesterol fodder. The order was as follows ; OVX>OVX+E+1.0P>OVX+E+0.3P>OVX+E+0.1P>OVX+E>C. The endothelium-dependent relaxation was smaller in the same order as above. On the other hand, there were no significant differences in those rabbits of the different concentrations of progesterone. It seemed that those concentrations and the number of subjects should be considered. In conclusion, estrogen enhanced relaxation even in the atherosclerotic vessels and progesterone reduced the inhibition of median hyper trophy by estrogen.
已知雌激素通过对脂质代谢的影响和对血管功能的作用来抑制动脉粥样硬化的发展。在本研究中,研究卵巢类固醇、雌激素和黄体酮如何作用于血管壁和子宫内膜。六个月大的白化兔被分为六组; C(假手术)、OVX(卵巢切除术)、OVX+E(戊酸雌二醇;5mg/体/2周)、OVX+E+1.0P(17α-羟孕酮己酸酯;125mg/体/2周)、OVX+E+0.3P、Ovx+E+0.1P。这些兔子被提供含有 0.5% 胆固醇的商业饲料,并每两周给予这些类固醇。六个月后他们被终止,并制作样本用于显微镜和张力记录。 OVX胸主动脉中层厚度为844±78μm;比非胆固醇饲料粗2.5倍。顺序如下: OVX>OVX+E+1.0P>OVX+E+0.3P>OVX+E+0.1P>OVX+E>C。与上述相同的顺序,内皮依赖性松弛较小。另一方面,不同浓度黄体酮的兔子之间没有显着差异。似乎应该考虑这些浓度和受试者数量。总之,雌激素甚至在动脉粥样硬化血管中也能增强松弛作用,而黄体酮则减少了雌激素对中位肥厚的抑制作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
R. Ogata, K. Kitamura, Y. Ito, H Nakano: "Inhibitory Effects of Genistein on ATP-Sensitive K-Channels in Rabbit Portal Vein Smooth Muscle"British Journal of Pharmacology. 122. 1395-1404 (1997)
R. Ogata、K. Kitamura、Y. Ito、H Nakano:“染料木黄酮对兔门静脉平滑肌 ATP 敏感 K 通道的抑制作用”英国药理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
緒方りか: "日本人女性の血管機能とHRT"日本更年期医学会雑誌. 7・1. 66-70 (1999)
Rika Ogata:“日本女性的血管功能和 HRT”,日本更年期医学会杂志 7・1(1999 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
野崎雅裕: "閉経による心血管系の変化及びその機序に関する研究"日本産科婦人科学会雑誌. 49・8. 552-562 (1997)
野崎正弘:“绝经引起的心血管系统变化及其机制的研究”日本妇产科学会杂志49・8(1997)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M. Nozaki, Y. Inoue, K. Hashimoto, R. Ogata, H. Nakano: "Differential time- related effects of conjugated equine estrogen on bone metabolism in oophorectomized women"Int. J. Gynecol. Obstet.. 60. 41-46 (1998)
M. Nozaki、Y. Inoue、K. Hashimoto、R. Ogata、H. Nakano:“结合马雌激素对卵巢切除女性骨代谢的不同时间相关影响”Int。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Nozaki,et al.: "Trearment of bone loss in oophorecimized women with a comoination or ipriflavone and conjugated equine estrogen." International Journal of Gynecology and Obstetrics. 62. 69-75 (1998)
M.Nozaki 等人:“用异丙黄酮和结合马雌激素治疗卵巢切除妇女的骨质流失。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NOZAKI Masahiro其他文献
NOZAKI Masahiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NOZAKI Masahiro', 18)}}的其他基金
RESEARCH FOR THE EFFECTS OF OVARIAN STEROIDS ON THE CONTRACTION AND RELAXATION OF VASCULAR SMOOTH MUSCLE CELLS OBTAINED FROM FEMALE ANIMAL.
卵巢类固醇对雌性动物血管平滑肌细胞收缩和舒张作用的研究。
- 批准号:
06671661 - 财政年份:1994
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Study of oviductal spontaneous contraction in relation to reciprocal controlling mechanism between fallopian tube and gamete or embryo.
输卵管自发收缩与输卵管与配子或胚胎相互控制机制的研究。
- 批准号:
03670791 - 财政年份:1991
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
SBIR Phase II: Novel progesterone biosensor for monitoring fertility health
SBIR II 期:用于监测生育健康的新型黄体酮生物传感器
- 批准号:
2341568 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Cooperative Agreement
Development of individualized treatment for endometriosis based on genomic profile and progesterone responsivness
基于基因组谱和黄体酮反应性的子宫内膜异位症个体化治疗的开发
- 批准号:
23K15819 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Sexual dimorphism in right (-sided) heart failure: Role of sphingosine kinsae-1 and progesterone in right ventricular angiogenesis and remodelling
右(侧)心力衰竭的性别二态性:鞘氨醇 kinsae-1 和黄体酮在右心室血管生成和重塑中的作用
- 批准号:
479618 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Operating Grants
Unravelling mechanisms and novel therapeutic targets for progesterone-resistant endometrial hyperplasia
揭示黄体酮抵抗性子宫内膜增生的机制和新的治疗靶点
- 批准号:
10710998 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Progesterone and allopregnanolone of prefrontal cortical activity dynamics and heroin seeking
黄体酮和四氢孕酮对前额皮质活动动力学和海洛因寻求的影响
- 批准号:
10644613 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Structural dynamics of progesterone receptor-coactivator complexes
黄体酮受体-辅激活剂复合物的结构动力学
- 批准号:
10626857 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Sex differences in SUDEP susceptibility: the role of progesterone and estradiol
SUDEP 易感性的性别差异:孕酮和雌二醇的作用
- 批准号:
10312862 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Arsenic suppresses progesterone receptor signaling and promotes tamoxifen resistance and metastasis of ER+ breast cancer
砷抑制孕激素受体信号传导并促进 ER 乳腺癌的他莫昔芬耐药性和转移
- 批准号:
10662054 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Molecular mechanisms of endometrial progesterone resistance
子宫内膜黄体酮抵抗的分子机制
- 批准号:
10618181 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Progesterone promotes mammary gland tumorigenesis through immunosuppressive effects on dendritic cells
黄体酮通过对树突状细胞的免疫抑制作用促进乳腺肿瘤发生
- 批准号:
10626769 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:














{{item.name}}会员




